A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma ( CT1190B-CG1101 )

NCT07032324 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

B-Cell Non-Hodgkin Lymphoma

Interventions

DRUG: CAR T cells

Sponsor

Qian Wenbin

Collaborators

[object Object]